Research
Hormonal
Weekly tirzepatide 10 and 15 mg resulted in more weight loss than weekly semaglutide 2.4 mg, daily semaglutide 0.4 mg, or liraglutide 3 mg.
Tirzepatide may be a more effective option for weight loss in obese adults compared to other GLP-1RAs.
StrongSupportsmedium confidence
Weekly tirzepatide 10 and 15 mg resulted in more weight loss than weekly semaglutide 2.4 mg, daily semaglutide 0.4 mg, or liraglutide 3 mg.
Why this rating
Based on a network meta-analysis of seven RCTs with over 12,300 patients.
Source
Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials
Omar S. Alkhezi et al. · Obesity Reviews · 2022
Meta-analysisCited 132×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →